Etoricoxib is a selective COX-2 inhibitor used as an active pharmaceutical ingredient. It is approved in many countries for use in pharmaceutical manufacturing, though not in the United States, where additional data were requested by the FDA.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Etoricoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Safinamide mesylate
pharmaceutical raw material
Clofazimine
pharmaceutical raw material
Laninamivir octanoate
pharmaceutical raw material
Recoflavone
pharmaceutical raw material
The international HS code for Etoricoxib (CAS 202409-33-4) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine
MNJVRJDLRVPLFE-UHFFFAOYSA-N
CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
Sourcing Etoricoxib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.